Hide and Seq

Personalized Cancer Therapy

Health Tech & Life Sciences
Non Active, Jan 2018

Company Overview

Snapshot

Founded in April 2016 by Shabtai Shoval, Alona Zilberberg, Rotem Ben-Hamo, and Sol Efroni, Hide and Seq operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing an in vitro diagnostic genomic signature for personalized cancer treatment.

Business overview

Hide and Seq is a Health Tech & Life Sciences company focused on personalized cancer therapy. The company develops an in vitro diagnostic genomic signature that combines predictive and prognostic biomarkers to identify patients who would benefit from alternative chemotherapy treatments. Its core product is a predictive assay for first-line therapy designed to detect chemotherapy resistance to paclitaxel in patients with metastatic ovarian cancer, aiming to provide personally tailored treatment modes to increase efficacy and survival. Hide and Seq operates within the Medical Devices and Diagnostics Devices sectors, targeting healthcare providers and women's health within the broader healthcare and life sciences market.

Strategic signal

In May 2016, Hide and Seq announced a collaboration with AbbVie, signaling early validation for its personalized cancer treatment approach. This partnership highlights the company's potential to attract significant industry interest for its diagnostic genomic signature technology, which aims to improve treatment outcomes for cancer patients.

Company Intelligence Q&A

What is Hide and Seq's primary focus?
Hide and Seq focuses on personalized cancer therapy, developing an in vitro diagnostic genomic signature to identify effective treatment options for various cancer types.
When was Hide and Seq founded?
Hide and Seq was founded in April 2016.
What is the company's core product?
The company is developing a predictive assay for first-line therapy aimed at identifying chemotherapy resistance to paclitaxel in patients with metastatic ovarian cancer.
Who are the founders of Hide and Seq?
Hide and Seq was founded by Shabtai Shoval, Alona Zilberberg, Rotem Ben-Hamo, and Sol Efroni.
What significant collaboration did Hide and Seq announce?
In May 2016, Hide and Seq announced a collaboration with AbbVie concerning its personalized cancer treatment initiatives.

External links